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Abstract: In this article we provide an overview of the newest data concerning the effect of 
non-alcoholic  constituents  of  alcoholic  beverages,  especially  of  beer,  on  pancreatic 
secretion, and their possible role in alcoholic pancreatitis and pancreatic carcinoma. The 
data indicate that non-alcoholic constituents of beer stimulate pancreatic enzyme secretion in 
humans and rats, at least in part, by direct action on pancreatic acinar cells. Some non-
alcoholic compounds of beer, such as quercetin, resveratrol, ellagic acid or catechins, have 
been  shown  to  be  protective  against  experimentally  induced  pancreatitis  by  inhibiting 
pancreatic  secretion,  stellate  cell  activation  or  by  reducing  oxidative  stress.  Quercetin, 
ellagic  acid  and  resveratrol  also  show  anti-carcinogenic  potential  in  vitro  and  in  vivo. 
However,  beer  contains  many  more  non-alcoholic  ingredients.  Their  relevance  in  
beer-induced functional alterations of pancreatic cells leading to pancreatitis and pancreatic 
cancer in humans needs to be further evaluated. 
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1. Introduction  
Alcoholic  beverages  contain  numerous  non-alcoholic  compounds  that  could  have  beneficial  or 
pathological effects. For example, more than 2,000 organic and inorganic constituents in beer and more 
than 1,000 in wine were identified to date. Whereas the role of alcohol (ethanol) in the development of 
pancreatic diseases—in particular acute and chronic pancreatitis—has been intensively investigated, 
only little is known about the effects of non-alcoholic compounds in this context. Some of the non-
alcoholic constituents have been shown to be biologically active, although the results are often not 
discussed  in  appropriate  publications  in  regard  to  their  consumption  as  an  inherent  mixture  in  
alcoholic beverages.  
This  review  summarizes  the  present  knowledge  about  the  effect  of  beer  and  other  alcoholic 
beverages on the pancreas in comparison to pure ethanol. Firstly, the article focuses on investigations 
with beer in human pancreatic secretion in vivo and rat pancreatic secretion in vitro. The second part 
briefly describes the current evidence on the link between beer consumption and pancreatitis based on 
epidemiological data. Subsequently, data concerning the effects of selected non-alcoholic compounds 
of beer on experimentally-induced pancreatitis in animals are presented. Studies that deal with the 
cancer preventive potential of the non-alcoholic compounds of beer are discussed in the fourth part.  
2. Results and Discussion  
2.1. Beer and Pancreatic Secretion 
Because hypersecretion of pancreatic enzymes has been observed in chronic alcoholics, a general 
impression is that ethanol stimulates basal (interdigestive) pancreatic exocrine secretion [1]. In the 
literature,  various  effects  of  alcohol  consumption  on  pancreatic  exocrine  secretion  have  been 
demonstrated,  which  may  be  due  to  the  route  of  administration  and  different  experimental  
conditions  [2].  Whereas  acute  oral  and  intragastric  ethanol  administration  increases  pancreatic 
bicarbonate and protein secretion, intravenous ethanol administration reduces basal and hormonally 
stimulated pancreatic bicarbonate and protein secretion. However, alcohol is commonly consumed as a 
tasty beverage that is a complex mixture with non-alcoholic compounds, a number of these which may 
also possibly influence pancreatic secretion.  
Studies  on  human  pancreatic  secretion  suggest  different  effects  of  alcoholic  beverages  when 
compared  to  appropriate  ethanol  solutions  [3-5].  Intragastric  administration  of  beer  in  a  volume  
(250 mL) that does not alter plasma ethanol concentrations causes a significant stimulation of basal 
pancreatic enzyme output, whereas ethanol in concentrations similar to beer (4% v/v) has no effect [3]. 
Therefore, the non-alcoholic constituents might be responsible for the stimulatory effect of beer on 
pancreatic enzyme secretion in humans. The intragastric administration of an higher amount of beer 
(850 mL) or white wine (400 mL) elevates plasma ethanol concentrations, but does not affect the basal 
pancreatic enzyme output [5]. It was suggested that the direct inhibitory effect of circulating ethanol 
neutralized the stimulatory effect of the non-alcoholic components of beer.  
In a study with healthy humans, Chari et al. (1996) found that isotonic glucose solution (5.76% w/v) 
as  well as  glucose solution  with  a concentration found in  finished wort  (11.5% w/v) were strong Int. J. Environ. Res. Public Health 2010, 7                 
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releasers of cholecystokinin (CCK), but stimulated the exocrine pancreatic secretion only moderately 
as  compared  to  beer.  These  results  suggest  that  CCK  is  one,  but  not  the  exclusive,  mediator  of 
pancreatic secretion induced by beer. However, direct effects of beer on enzyme secretion has not been 
examined, and can not necessarily be inferred from infusion or injection studies because of potential 
interaction with enteropancreatic reflexes [6], other hormones [7-9] or regulators [9,10] in vivo.  
Therefore, recent studies investigated the direct effect of alcoholic beverages, especially beer, on 
pancreatic secretion of freshly isolated rat pancreatic acinar cells and the rat pancreatic acinar cell line 
AR4-2J  [11,12].  The  cell  line  retains  many  of  the  characteristics  of  pancreatic  acinar  cells  in  its 
differentiated state and is a general model to study stimulus-secretion coupling [13]. Stimulation of 
AR4-2J cells with different alcoholic beverages and appropriate ethanol solutions have shown that 
increasing beer dose increases amylase release, whereas pure ethanol, wine or alcoholic beverages 
produced by distillation (e.g., whisky, tequila) have no effect (Figure 1). 
Figure  1.  Effect of beer (white bars), ethanol (black bars), red wine (spotted bar) and 
whisky (striped bar) on basal amylase release in AR4-2J cells. Volumes are expressed as % 
of test solution in incubation buffer. Adapted from [12]. 
 
 
This  effect  was  reproducible  in  freshly  isolated  pancreatic  acinar  cells.  Lactate  dehydrogenase 
measurement after long-term treatment (24 h) of AR4-2J cells indicated that the beer-induced amylase 
release is not due to protein release due to cell membrane damage [12]. Pre-treatment of AR4-2J cells 
with selective inhibitors of known mediators of stimulus-secretion coupling in pancreatic acinar cells 
has shown that beer-induced amylase secretion is mediated by activation of phospholipase C (PLC), 
binding of IP3 to its receptor (IP3-R) and subsequent calcium release from intracellular stores. The 
participation of calcium in beer-induced amylase release was confirmed by pre-treatment of the cells 
with the calcium chelator BAPTA/AM and measurement of fluorescence after loading the cells with Int. J. Environ. Res. Public Health 2010, 7                 
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the  calcium  indicator  Fura-2  AM.  However,  further  results  indicate  that  additional,  yet  unknown, 
signaling pathways are involved in the beer-induced amylase release [11].  
Concerning the characterization of the compounds that are responsible for the stimulatory effect of 
beer  in  vitro,  we  have  shown  that  barley  is  the  source  of  the  stimulants  and  malting  as  well  as 
fermentation  have  just  a  marginal  effect  on  the  stimulatory  action.  In  addition,  fermented  and 
unfermented glucose in concentrations found in finished wort, as well as the known stimulants of 
gastric secretion, maleic acid and succinic acid, have no effect on pancreatic secretion of AR4-2J cells. 
Stimulation  of  cells  with  treated  beer  (distillation,  lyophilization,  dialysis  and  protease  digestion) 
suggested that the stimulatory compound/s is/are heat-stable, non-volatile substance/s with a molecular 
weight higher than 15 kDa [11]. 
2.2. Beer and Pancreatitis 
Alcohol is the major etiological factor of acute and chronic pancreatitis (for recent review see [14]). 
Alcohol  is  responsible  for  up  to  40%  of  the  acute  pancreatitis  cases,  and  60−90%  of  chronic 
pancreatitis patients have a history of chronic alcohol consumption [15]. However, the fact that only a 
minority of less than 10% of heavy drinkers develop alcoholic pancreatitis [16] and that ethanol alone 
can not induce pancreatic inflammation in animal experiments [17] promoted an intensive search for 
cofactors of the development of chronic pancreatitis. These include diet, smoking, type of alcoholic 
beverage consumed, pattern of drinking, lipid intolerance and inherited factors [18,19].  
The influence of beverage type on the development of pancreatitis remains controversial (for review 
see [20]). Wilson et al. [21] compared alcoholic pancreatitis patients with alcoholic cirrhosis patients 
and found a slight tendency to consume less beer and more wine in the latter. Nakamura et al. [22] 
found that spirits increased the risk for chronic pancreatitis more than sake and beer in 111 Japanese 
alcoholics, without significant difference in the total amount of ethanol consumed. A more recent study 
of  the  same  authors  reported  that  the  amount  of  alcohol  consumed  per  day  was  greater  in  spirit 
drinkers, suggesting that the higher alcohol consumption may be associated with the higher risk of 
pancreatitis [23]. The latest population-based cohort study of Kristiansen et al. [24] analysed a hazard 
ratio of 2.0 for the development of pancreatitis with drinking of more than 14 glasses of beer/week, 
whereas no association was observed for wine and spirits. However, this study was limited due to only 
a few participants with a high consumption (≥14 drinks/week) of both wine and spirits (eight and eight 
drinks/week, respectively) versus 49 drinks/week for beer.  
2.3. Non-Alcoholic Constituents of Beer and Pancreatitis 
Beer is an extremely complex beverage, and thousands of constituents have been identified hitherto. 
However,  one  of  the  differentiating  characteristics  among  alcoholic  beverages  is  their  polyphenol 
composition. In this context, wine contains more abundant polyphenols than beer and liquors. In beer, 
more  than  50  polyphenolic  compounds  were  identified  [25].  About  75–85%  of  these  polyphenols 
derive from malt and 15–25% from hop. The polyphenol content of each beer is largely affected by the 
type and the sort of corn (barley, wheat), the type of hop, as well as by the different processes to 
produce the malt, wort and hop extract.  Int. J. Environ. Res. Public Health 2010, 7                 
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The best studied polyphenol is resveratrol, which is a phenolic phytoalexin present in grape skins 
and wines (especially red wines) and was also found in beer. Some recent studies demonstrated a 
protective  effect  of  resveratrol  on  experimentally  induced  acute  pancreatitis  in  animal  models. 
Szabolcs et al. [26] examined the effect of resveratrol on CCK-induced acute pancreatitis in male 
Wistar rats. Pre-treatment with 10 mg/kg body weight resveratrol ameliorated CCK-induced changes 
of  laboratory  parameters  such  as  amylase,  lipase,  glucose,  calcium,  creatinine  and  aspartate 
aminotransferase  activities  as  well  as  the  serum  concentration  of  triglyceride  and  urea  nitrogen. 
Furthermore, a reduced extent of tissue edema, acinar vacuolization and total histological damage was 
found by histological investigation of the pancreas after resveratrol treatment. Since no inhibition of 
nuclear factor (NF)-κB activation by resveratrol was found, it was concluded that the beneficial effects 
of resveratrol seem to be mediated by the anti-oxidant effect of resveratrol or by an anti-inflammatory 
mechanism independent of NF-κB. 
In contrast to this, activation of NF-κB in macrophages is involved in the inflammatory response of 
rats with sodium taurocholate-induced severe acute pancreatitis (SAP). Resveratrol (10 mg/kg body 
weight) decreased the NF-κB activation as well as expression of inducible nitric oxide synthase (iNOS) 
in peritoneal macrophages [27]. In addition, in resveratrol-treated SAP rats, serum levels of tumor 
necrosis factor (TNF)-α, interleukin (IL)-1 and nitric oxide were also reduced at 3, 6 and 12 hours after 
induction of SAP. An attenuation of various pathological manifestations by resveratrol as compared to 
untreated SAP group was also found by histological examinations of the pancreas. These results were 
confirmed by further studies showing the inhibitory effect of resveratrol on expression of NF-κB and 
the levels of TNF-α and IL-8 in pancreatic tissues of SAP-rats [28], as well as reduction of intracellular 
calcium overload, which otherwise leads to tissue damage in this model [29].  
Previous studies have shown that pancreatic damage in experimental pancreatitis can be reduced by 
hepatocyte growth factor (HGF). Warzecha et al. [30] investigated the effect of resveratrol on HGF in 
cerulein-induced pancreatitis in Wistar rats. In contrast to the study of Meng et al. [28] treatment with 
10 mg/kg resveratrol alone had no effect on the development of pancreatitis. Resveratrol did not affect 
lipase activity, concentrations of IL-1ß  and IL-10 in the plasma as well as pancreatic DNA synthesis. In 
addition,  resveratrol  did  not  affect  the  protective  effect  of  HGF.  Since  it  has  been  shown  that 
resveratrol is an inhibitor of cyclooxygenase-1 activity, it can be concluded that this activity is not 
involved in the protective effect of HGF in acute pancreatitis.  
Oxidative stress is another important process that may play a role in pancreatic injury. Evidence of 
oxidative  stress  has  also  been  reported  in  the  pancreas  of  patients  with  alcoholic  chronic  
pancreatitis [2]. The effect of resveratrol on pancreatic oxygen free radicals was investigated in rats 
with  severe  acute  pancreatitis  [31].  Histological  examinations  showed  that  resveratrol  treatment  
(20 mg/kg body weight) after induction of acute pancreatitis led to a significant reduction of turbidity 
ascitic  fluid,  pancreatic  edema,  necrosis  and  inflammatory  cell  infiltration  as  compared  to  the 
pancreatitis group. In addition, resveratrol treatment significantly diminished serum amylase, inhibited 
the formation of the lipid peroxidation product malondialdehyde (MDA) and increased the pancreatic 
superoxide dismutase (SOD, an internal anti-oxidase). Measurement of myeloperoxidase (MPO) as an 
indicator of neutrophil sequestration, another source of oxygen free radicals during acute pancreatitis, 
showed  a  reduction  of  this  enzyme  in  the  resveratrol-treated  group.  An  attenuation  of  various Int. J. Environ. Res. Public Health 2010, 7                 
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pathological manifestations (less pronounced necrotic changes of rat pancreata such as focal edema, 
acinar cell vacuolization, and focal tissue necrosis) as well as a decrease of serum amylase activity 
were also found by treatment with 2 mg resveratrol for eight days before induction of acute pancreatitis 
with free radicals (tert-butyl hydroperoxide) in male Wistar rats [32].  
In conclusion, resveratrol has a protective effect on pancreatic damage by lowering oxidative free 
radicals and reducing tissue infiltration of neutrophils. Resveratrol may be considered as an agent for 
reducing the inflammatory response in acute pancreatitis.  
Similar effects were found for the effect of catechins on ethionine-induced acute pancreatitis in 
male Wistar rats [33]. Catechins are phytoalexins, which are found in green tea, various vegetables and 
fruits and particularly in paring of grapes of red wines as well as beer. Morphological analysis of rats 
that were supplied with 0.2% solution of green tea extract (GTE, 91.2% catechins) for 13 days prior to 
injection of 800 mg/kg ethionine, showed few lesions on pancreatic tissue except for mild interstitial 
edema, whereas in rats without GTE treatment inter- and intrastitial edema and necrosis of acinar cells 
were found. A significant decrease in serum amylase activity and tissue lipid peroxides concentration 
was also found in GTE-drinking rats, as compared to the ethionine-treated group supplied with water. 
Similar  results  were  reported  by  the  same  author  for  the  effects  of  catechins  on  cerulein-induced 
pancreatitis  [34].  Certain  catechins  have  anti-oxidative  properties  by  eliminating  superoxide  and 
hydroxyl radicals. Thus, it could be shown that a 0.1% solution of green tea catechins as drinking water 
had a protective effect against the oxidative stress in pancreas and liver induced by the pancreatic 
carcinogen  N-nitro-sobis(2-oxopropyl)amine  in  Syrian  golden  hamsters  [35].  The  increase  of  
8-hydroxydeoxyguanosine content in nuclear DNA, which is a biomarker of DNA oxidative damage, 
was inhibited by green tea catechins. In addition, an inhibitory effect of green tea catechins was also 
shown on lipid peroxidation confirming the protective effect of catechins on oxidative stress.  
In contrast, the same authors showed that GTE do not suppress the lipid hydroperoxide-induced  
8-oxodG  (biomarker  for  oxidative  stress  and  carcinogenesis)  increase  in  pancreas,  but  slightly 
suppressed the amount in liver [36]. Taken together, catechins were shown to have a protective effect 
on experimental-induced pancreatitis in rats. 
In cerulein-induced pancreatitis, heat shock protein 70 (HSP70) prevents secretagogue-induced cell 
injury in the pancreas of Wistar rats by preventing intracellular trypsinogen activation [37]. Incubation 
of cultured pancreas fragments with 50 µM quercetin completely blocked culture-induced upregulation 
of  HSP70  expression  and  restored  the  culture-dependent  loss  of  trypsinogen  activation  in  the  
cerulein-induced pancreatitis. Quercetin is a naturally occurring flavonoid present in a variety of plants 
and in beer and wine and has important anti-degenerative properties [38]. Studying non-pancreatic 
tissues it was  shown that quercetin inhibits  synthesis  of HSP110, HSp90,  HSP40, and HSP28, in 
addition to HSP70. 
Pancreatic stellate cells (PSCs) are the main source of extracellular matrix synthesis leading to 
pancreatic fibrosis and are activated by growth factors, inflammatory cytokines, alcohol, its metabolite 
acetaldehyde and oxidative stress [39]. Recently, it has been shown, that ellagic acid has crucial effects 
on a number of cell functions including activation of PSCs in vitro [40]. Ellagic acid is a polyphenol 
mainly found in fruits (raspberries, strawberries), nuts (walnuts) and wood, but also in beer and in  
wine [25,40]. Ellagic acid inhibited the platelet derived growth factor (PDGF)-induced proliferation Int. J. Environ. Res. Public Health 2010, 7                 
 
 
1099 
and  migration  in  a  dose-dependent  manner  (1−25  µg/mL)  without  affecting  cell  viability.  At  a 
concentration of 10 µg/mL, ellagic acid inhibited PDGF-induced tyrosine phosphorylation of PDGF  
ß -receptor and the activation of the downstream signalling pathways (extracellular signal-regulated 
protein kinase and Akt). Furthermore, ellagic acid significantly inhibited several key functions of PSCs 
including  activator  protein-1,  α-smooth  muscle  actin  gene  expression,  monocyte  chemoattractant 
protein-1  production  and  collagen  expression  in  a  dose-dependent  manner.  In  addition,  the 
transformation of freshly isolated PSCs from quiescent to myofibroblast-like phenotyp in culture was 
also blocked by ellagic acid. Because of these crucial effects on cell functions and the activation of 
PSCs ellagic acid is a potential candidate for the treatment of pancreatic fibrosis and inflammation.  
2.4. Beer and Carcinogenesis 
Pancreatic  carcinoma,  particularly  pancreatic  ductal  carcinoma,  is  characterized  by  extremely 
aggressive  behavior,  with  an  overall  five-year  survival  of  less  than  4%  [41].  Since  therapeutic 
specimens have only little impact on patient survival, epidemiological studies and molecular research 
focus on identification and reduction of risk factors. Epidemiological data suggest a slight, but not 
significant  increase  in  risk  for  pancreatic  carcinoma  for individuals  consuming 30 or  more grams 
alcohol per day [42]. However, there is an indirect relationship, since ethanol induces the development 
of chronic pancreatitis and this can lead to pancreatic carcinoma [43]. The cumulative risk for the 
development of pancreatic carcinoma in the presence of chronic pancreatitis for 10 and 20 years is 
equal to 1.8% and 4.0%, respectively. The risk is not related to the sex of the patients, the geographical 
location,  or  the  etiology  of  pancreatitis  [43].  Therefore,  chronic  pancreatitis  can  be  regarded  as  a 
precancerous disease.  
Flavonols are a class of flavonoids, polyphenols, which are ubiquitous in plant foods and are known 
compounds of beer. A recent cohort study evaluated the participants’ food consumption and calculated 
the  intake  of  the  three flavonols: quercetin, kaempferol, and  myricetin. These results  showed that 
flavonol intake reduces the risk for developing pancreatic cancer [44].  
In addition, different polyphenols (quercetin, ellagic acid and resveratrol) were shown to have an 
inhibitory effect on pancreatic cancer growth in vivo and in vitro (Table 1). In detail, treatment with a 
daily dose of quercetin (1.3 mg i.p.) in a nude mouse model of pancreatic cancer as well as incubation 
of  pancreatic  carcinoma  cell  lines  (human  Mia  PACA-2,  rat  BSp73AS)  with  100  µM  quercetin, 
showed multiple effects on pancreatic cancer: prevention of metastatic lesions, decrease of primary 
tumor growth and induction of apoptosis in tumor cells [45].  
Ellagic  acid  at  concentrations  of 10−50 mmol/L stimulated apoptosis  in  human pancreatic Mia 
PACA-2 and PANC-1 tumor cells. In addition, ellagic acid decreased proliferation by up to 20-fold at 
50  mmol/L  and  stimulated  the  mitochondrial  pathway  of  apoptosis  associated  with  mitochondrial 
depolarization, cytochrome C release, and the downstream caspase activation.  In a dose-dependent 
manner,  ellagic  acid  decreased  NF-kB  binding  activity;  inhibition  of  NF-kB  activity  using  IkB 
prevented  the  effect  of  ellagic  acid  on  apoptosis.  Therefore,  the  data  indicate  that  ellagic  acid 
stimulates apoptosis through inhibition of the pro-survival transcription factor NF-kB [46].  
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Table  1.  Studies  on  the  effects  of  non-alcoholic  constituents  of  beer  on  pancreatic 
carcinoma. 
Compound  Experimental 
Design 
Effect on Pancreas  Species  Reference 
Quercetin  in vivo 
1.3  mg  daily, 
initiated  10  days 
after  tumor 
transplantation  
Decrease  of  the  primary 
tumor growth 
Prevention  of  metastatic 
lesion 
 
Nude Mouse  
 
[45] 
  in vitro 
<100 µ M 
Induction  of  apoptosis  by 
mitochondrial 
depolarization,  cytochrome 
c  release  and  caspase 
activation 
Rat 
(BSp73AS 
cell line) 
Human  
(Mia PACA-2 
cell line) 
[45] 
Ellagic acid  in vitro 
10−50 mM 
Induction  of  apoptosis  by 
mitochondrial 
depolarization,  cytochrome 
c  release  and  caspase 
activation 
Decrease of NF-kB binding 
activity 
Human  
(Mia PACA-2 
and PANC-1 
cell line) 
[46] 
Resveratrol  in vitro 
<100 µM  
 
Induction  of  apoptosis  by 
mitochondrial 
depolarization,  cytochrome 
c  release  and  caspase 
activation 
Rat 
(BSp73AS 
cell line) 
Human  
(Mia PACA-2 
cell line) 
[45] 
  in vitro 
100 µ M 
Inhibition  of  proliferation 
and induction of apoptosis  
Change  of  cell  cycle 
distribution 
Human 
(PANC-1 and 
AsPC-1 cell 
line) 
[47] 
Proanthocyanidins 
 
in vivo 
0.025  and  0.25% 
fed during or after 
experimentally 
induced tumor 
growth  
Inhibition  of  rat  pancreatic 
carcinogenesis  in  the 
initiation stage 
Rat  
(Sprague-
Dawley) 
[48] 
 
Further experiments indicated that also resveratrol but not rutin (glycosidic form of quercetin and 
one of the flavonoids most abundant in foods) activate apoptosis in pancreatic cancer cells [45]. The 
results  showed  an  inhibitory  effect  of  resveratrol  on  pancreatic  cancer  growth  by  inducing 
mitochondrial  dysfunction  followed  by  cytochrome  c  release,  caspase  activation  and  apoptosis.  In 
addition, resveratrol sensitized the cells to ionizing radiation [49]. A potent anti-proliferative effect of Int. J. Environ. Res. Public Health 2010, 7                 
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100  µM  resveratrol  has  also  been  described  in  human  pancreatic  cancer  cell  lines  PANC-1  and  
AsPC-1 [47]. 
A  protective  effect  has  also  been  found  for  proanthocyanidins  on  2-amino-1-methyl-6-
phenylimidazo[4,5-b]pyridine (PhIP)-induced mutagenesis in vitro and on in vivo carcinogenesis in 
Sprague-Dawley rats [48]. Proanthocyanidins can be found in many plants, most notably apples, pine 
bark, cinnamon, grape seed, cocoa, grape skin, red wines and beer. The eight-fold treatment with PhIP 
(100mg/kg body weight) over a period of four weeks resulted in acinar lesions in exocrine pancreas of 
all treated rats, which decreased dose-dependently by proanthocyanidins given during the initiation 
period.  Colon  lesions  were  not  observed  and  pituitary  lesions  such  as  hyperplasia,  adenoma  and 
hematoma, liver cell foci, uterine stromal polyps, small intestinal adenocarcinomas, and leukemia were 
sporadically  found  in  the  PhIP-treated  rats,  but  proanthocyanidins  did  not  appear  to  affect  
their development.  
 
3. Conclusion 
 
Beer, but not other alcoholic beverages or ethanol, stimulates pancreatic secretion in humans. This 
effect is, at least in part, mediated by direct effects of non-alcoholic compounds of beer on pancreatic 
acinar cells. It is conceivable that beer-induced alterations of the stimulus-secretion coupling contribute 
to the doubled risk to develop chronic pancreatitis for individuals with a daily high beer intake, which 
is described by Kristiansen et al. [24]. 
Single compounds of beer show rather a beneficial effect on experimentally-induced pancreatitis 
and pancreatic carcinoma. However, beer is an extremely complex mixture of bioactive substances and 
just a fraction of these compounds were tested for their effect/s on pancreatitis or pancreatic carcinoma. 
In  addition,  future  studies  should  also  focus  on  defined  combinations  of  substances  in  relevant 
concentrations, because one may assume that the effect/s of the mixture will differ from the effect of 
single components.  
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